SFS
VRTX icon

Sowell Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Sowell Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
2,930
+155
+6% +$68.7K 0.05% 379
2026
Q1 		$1.24M Sell
2,775
-39
-1% -$18.2K 0.05% 394
2025
Q4 		$1.28M Sell
2,814
-1,198
-30% -$516K 0.05% 378
2025
Q3 		$1.57M Buy
4,012
+1,215
+43% +$508K 0.06% 327
2025
Q2 		$1.25M Sell
2,797
-29
-1% -$13.4K 0.05% 358
2025
Q1 		$1.37M Buy
+2,826
New +$1.32M 0.06% 307
2023
Q2 		– Sell
-3,188
Closed -$1M – 835
2023
Q1 		$1M Buy
+3,188
New +$956K 0.08% 292
2021
Q2 		– Sell
-2,529
Closed -$539K – 2691
2021
Q1 		$539K Buy
2,529
+83
+3% +$18.2K 0.02% 616
2020
Q4 		$578K Buy
2,446
+283
+13% +$64.9K 0.02% 483
2020
Q3 		$589K Buy
2,163
+8
+0.4% +$2.21K 0.03% 432
2020
Q2 		$626K Buy
2,155
+368
+21% +$99.8K 0.03% 393
2020
Q1 		$425K Sell
1,787
-870
-33% -$200K 0.03% 432
2019
Q4 		$582K Buy
2,657
+489
+23% +$99K 0.04% 405
2019
Q3 		$367K Buy
+2,168
New +$384K 0.03% 485
2019
Q1 		$323K Hold
1,758
– – 0.04% 437
2018
Q4 		$291K Buy
1,758
+401
+30% +$69.5K 0.04% 393
2018
Q3 		$262K Buy
1,357
+50
+4% +$8.9K 0.04% 285
2018
Q2 		$229K Buy
+1,307
New +$203K 0.05% 256
2017
Q3 		– Sell
-2,762
Closed -$423K – 284
2017
Q2 		$423K Hold
2,762
– – 0.12% 154
2017
Q1 		$325K Buy
2,762
+23
+0.8% +$2.02K 0.1% 179
2016
Q4 		$245K Buy
+2,739
New +$223K 0.08% 170

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Sowell Financial Services's VRTX Position: Q2 2026 in Review

Sowell Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 5.6% in Q2 2026, buying an estimated $68.7K and bringing the position to 2,930 shares worth $1.46M. The position accounts for 0.05% of the portfolio, ranked #379.

Sowell Financial Services first reported a position in VRTX in Q4 2016 and has held it in 21 quarters since. The position peaked at $1.57M in Q3 2025. 327 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sowell Financial Services held 2,930 shares of Vertex Pharmaceuticals worth $1.46M as of Q2 2026.
  • Sowell Financial Services bought 155 Vertex Pharmaceuticals shares in Q2 2026, an estimated $68.7K.
  • Vertex Pharmaceuticals made up 0.05% of Sowell Financial Services's portfolio in Q2 2026, its #379 holding.
  • Sowell Financial Services first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 21 quarters since.
  • Sowell Financial Services's Vertex Pharmaceuticals position peaked at $1.57M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.